CZ299418B6 - DNA konstrukt, ovlivnující expresi endogenního IFNA2 genu, izolovaná nukleová kyselina, homologne rekombinantní savcí bunka, zpusob ovlivnení expreseendogenního IFNA2 genu a zpusob produkce IFNA2 - Google Patents
DNA konstrukt, ovlivnující expresi endogenního IFNA2 genu, izolovaná nukleová kyselina, homologne rekombinantní savcí bunka, zpusob ovlivnení expreseendogenního IFNA2 genu a zpusob produkce IFNA2 Download PDFInfo
- Publication number
- CZ299418B6 CZ299418B6 CZ20003705A CZ20003705A CZ299418B6 CZ 299418 B6 CZ299418 B6 CZ 299418B6 CZ 20003705 A CZ20003705 A CZ 20003705A CZ 20003705 A CZ20003705 A CZ 20003705A CZ 299418 B6 CZ299418 B6 CZ 299418B6
- Authority
- CZ
- Czechia
- Prior art keywords
- seq
- sequence
- cells
- endogenous
- ifna2
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8464898P | 1998-05-07 | 1998-05-07 | |
US8655598P | 1998-05-21 | 1998-05-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
CZ20003705A3 CZ20003705A3 (cs) | 2001-04-11 |
CZ299418B6 true CZ299418B6 (cs) | 2008-07-16 |
Family
ID=26771248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CZ20003705A CZ299418B6 (cs) | 1998-05-07 | 1999-05-05 | DNA konstrukt, ovlivnující expresi endogenního IFNA2 genu, izolovaná nukleová kyselina, homologne rekombinantní savcí bunka, zpusob ovlivnení expreseendogenního IFNA2 genu a zpusob produkce IFNA2 |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1075531A1 (tr) |
JP (1) | JP2002513580A (tr) |
KR (1) | KR20010052278A (tr) |
CN (1) | CN1309710A (tr) |
AR (1) | AR016264A1 (tr) |
AU (1) | AU3788899A (tr) |
CA (1) | CA2328459A1 (tr) |
CZ (1) | CZ299418B6 (tr) |
HU (1) | HUP0102517A3 (tr) |
IL (1) | IL139433A0 (tr) |
NO (1) | NO20005585L (tr) |
PL (1) | PL344517A1 (tr) |
TR (1) | TR200003271T2 (tr) |
WO (1) | WO1999057292A1 (tr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1647501A (en) | 1999-12-10 | 2001-06-18 | Cytos Biotechnology Ag | Replicon based activation of endogenous genes |
FR2817559B1 (fr) * | 2000-12-06 | 2003-12-12 | Genodyssee | Procede de determination d'un ou plusieurs polymorphisme(s) fontionnel(s) dans la sequence nucleique d'un gene "candidat" fonctionnel preselectionne et ses applications |
US9085627B2 (en) * | 2011-04-13 | 2015-07-21 | National Research Council Of Canada | Expression system with SAR element from IFNα2 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995031560A1 (en) * | 1994-05-13 | 1995-11-23 | Transkaryotic Therapies, Inc. | Dna construct for effecting homologous recombination and uses thereof |
-
1999
- 1999-05-05 TR TR2000/03271T patent/TR200003271T2/tr unknown
- 1999-05-05 HU HU0102517A patent/HUP0102517A3/hu unknown
- 1999-05-05 PL PL99344517A patent/PL344517A1/xx not_active Application Discontinuation
- 1999-05-05 IL IL13943399A patent/IL139433A0/xx unknown
- 1999-05-05 CN CN99808195A patent/CN1309710A/zh active Pending
- 1999-05-05 EP EP99920375A patent/EP1075531A1/en not_active Withdrawn
- 1999-05-05 CZ CZ20003705A patent/CZ299418B6/cs not_active IP Right Cessation
- 1999-05-05 JP JP2000547246A patent/JP2002513580A/ja active Pending
- 1999-05-05 KR KR1020007012066A patent/KR20010052278A/ko not_active Application Discontinuation
- 1999-05-05 CA CA002328459A patent/CA2328459A1/en not_active Abandoned
- 1999-05-05 AU AU37888/99A patent/AU3788899A/en not_active Abandoned
- 1999-05-05 WO PCT/US1999/009925 patent/WO1999057292A1/en not_active Application Discontinuation
- 1999-05-06 AR ARP990102133A patent/AR016264A1/es not_active Application Discontinuation
-
2000
- 2000-11-06 NO NO20005585A patent/NO20005585L/no not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995031560A1 (en) * | 1994-05-13 | 1995-11-23 | Transkaryotic Therapies, Inc. | Dna construct for effecting homologous recombination and uses thereof |
Non-Patent Citations (2)
Title |
---|
Geisel C. et al. : "The sequence of Homo sapiens PAC clone DJ0320J15", " EMBL Database AC004081", 3.2.1998 * |
Strong C. et al.: "The sequence of H. sapiens BAC clone GS009G13", EMBL database AC002479, 26.8.1997 * |
Also Published As
Publication number | Publication date |
---|---|
AU3788899A (en) | 1999-11-23 |
WO1999057292A9 (en) | 1999-12-16 |
NO20005585L (no) | 2001-01-05 |
EP1075531A1 (en) | 2001-02-14 |
JP2002513580A (ja) | 2002-05-14 |
PL344517A1 (en) | 2001-11-05 |
IL139433A0 (en) | 2001-11-25 |
AR016264A1 (es) | 2001-06-20 |
HUP0102517A2 (hu) | 2001-11-28 |
CA2328459A1 (en) | 1999-11-11 |
CZ20003705A3 (cs) | 2001-04-11 |
HUP0102517A3 (en) | 2004-06-28 |
CN1309710A (zh) | 2001-08-22 |
WO1999057292A1 (en) | 1999-11-11 |
NO20005585D0 (no) | 2000-11-06 |
TR200003271T2 (tr) | 2001-03-21 |
KR20010052278A (ko) | 2001-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20150027752A (ko) | 인간화된 il-7 설치류 | |
JPH11502122A (ja) | タンパク質生産および輸送 | |
JPH10500570A (ja) | 相同組換えに効果的なdna構築物及びその利用 | |
NZ507451A (en) | Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery and enhancement of g-csf transcription and translation trasfection and infection into mamalian cell | |
CN113544257A (zh) | 中国仓鼠卵巢细胞中内源性逆转录病毒的表征及灭活 | |
RU2229309C2 (ru) | МОДИФИЦИРОВАНИЕ ЭКСПРЕССИИ ГЕНА FSHβ С ПОМОЩЬЮ ГОМОЛОГИЧНОЙ РЕКОМБИНАЦИИ | |
CZ299418B6 (cs) | DNA konstrukt, ovlivnující expresi endogenního IFNA2 genu, izolovaná nukleová kyselina, homologne rekombinantní savcí bunka, zpusob ovlivnení expreseendogenního IFNA2 genu a zpusob produkce IFNA2 | |
LU501908B1 (en) | Preparation Method of Adeno-associated Virus with Epigenetic Modification Function and Application Thereof | |
JPH0568560A (ja) | ウシ筋原性因子の遺伝子 | |
CN1297910A (zh) | 新的人鸟苷酸释放因子及其编码序列 | |
CN1297943A (zh) | 人脑表达的x染色体连锁蛋白及其编码序列 | |
WO2004033493A1 (fr) | Proteine humaine de promotion de transformation de cellule 3t3 et sa sequence codante | |
WO1999058556A2 (en) | Protein associated to hereditary spastic paraplegia | |
CN1303929A (zh) | 一种新的多肽——核糖体蛋白18和编码这种多肽的多核苷酸 | |
CN1303938A (zh) | 一种新的多肽——人math37和编码这种多肽的多核苷酸 | |
CN1292386A (zh) | 一种新的多肽——hrmt35和编码这种多肽的多核苷 | |
CN1510045A (zh) | 一种多肽——人kringle蛋白8和编码这种多肽的多核苷酸 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of fee |
Effective date: 20090505 |